Idiopathic inflammatory myopathies: Definition and management of refractory disease
- 30 September 2011
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 10 (11) , 720-724
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Rituximab therapy for myopathy associated with anti–signal recognition particle antibodies: A case seriesArthritis Care & Research, 2010
- Intravenous immunoglobulins for steroid‐refractory esophageal involvement related to polymyositis and dermatomyositis: A series of 73 patientsArthritis Care & Research, 2010
- Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathiesArthritis Care & Research, 2010
- Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage indexArthritis & Rheumatism, 2009
- Myopathies inflammatoires : diagnostic et classificationsLa Presse Médicale, 2009
- Rituximab treatment of the anti-synthetase syndrome—a retrospective case seriesRheumatology, 2009
- Clinical Characteristics and Outcomes of Juvenile and Adult DermatomyositisJournal of Korean Medical Science, 2009
- Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomesArthritis Research & Therapy, 2007
- Prognosis and mortality of polymyositis and dermatomyositis patientsClinical Rheumatology, 2006
- Successful Combined Therapy of Cyclophosphamide and Cyclosporine for Acute Exacerbated Interstitial Pneumonia Associated with Dermatomyositis.Internal Medicine, 2000